Articles by Nesa Nourmohammadi
Oregon Health & Science University (OHSU) researchers think the inability to find an effective AIDS vaccine may come down to not finding the right virus strain to make one.
With about 26,000 new cases of pertussis recorded so far this year, 2012 has marked the largest outbreak of the disease in the past 50 years, and scientists say more research is needed to find a better vaccine.
Seasonal allergies may not be fatal, but are nothing to sneeze at. Fortunately, British researchers think their potential vaccine could be a cheaper and more efficient way to combat hay fever than traditional therapies already on the market.
CSL will manufacture and store antigens that can be used against influenza strains with pandemic potential.
Prevnar 13 is the first and only pneumococcal vaccine to be granted WHO prequalification for adults.
Lackluster results from a recent clinical trial has cast doubts on Sanofi's dengue fever vaccine, not to mention the Big Pharma's future sales expectations.
In a post-9/11 world, fears over pandemics and bioterrorism have renewed drug and vaccine development in the public sector, as national governments funnel research toward combating infectious diseases, like anthrax.
In Oklahoma, one of the states hit worst by the West Nile virus this year, researchers at the University of Oklahoma Health Sciences Center are working on a vaccine, and the findings have been promising so far.
On the Tanzanian island of Zanzibar, some individuals may not even need a vaccine to protect them against cholera. Research shows herd immunity has helped guard against the disease in sub-Saharan Africa.
Riding the wave of a successful Phase I trial down under and $20 million in VC funding, Massachusetts biotech ImmusanT has launched a clinical trial in the U.S. for Nexvax2, its experimental vaccine to treat celiac disease.